Molekulyarnye funktsii magniy-zavisimykh belkov miokarda ukazyvayut na perspektivy kardiologicheskogo primeneniya preparatov na osnove orotata magniya
- Authors: Torshin I.Y.1, Gromova O.A2
-
Affiliations:
- FSAEI HPE "Moscow Institute of Physics and Technology"
- SBEI HPE "Ivanovo State Medical Academy" of RMPH
- Issue: No 9 (2016)
- Pages: 54-59
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/288987
- ID: 288987
Cite item
Open Access
Access granted
Abstract
The article presents modern data on the regulatory effect of magnesium on the cardiovascular system. Cardioprotective effects of magnesium are substantiated. Significance of magnesium-dependent proteins, supporting the function of the myocardium, is considered. The best ways to correct magnesium deficiency, particularly in cardiac patients, are discuss. The use of second generation magnesium preparations, containing organic magnesium salts with high bioavailability, is most promising. Magnesium orotate - is one of such drugs. The efficiency of magnesium orotate in conditions with magnesium deficiency, especially in patients undergoing coronary surgery, is demonstrated. The drug has antiarrhythmic, vasodilating and cardioprotective effects. Increasing myocytes resistance to ischemia, magnesium orotate has positive effect on the clinical course of myocardial infarction and heart failure. Orotate magnesium is also effective in idiopathic mitral valve prolapse
Full Text
About the authors
I. Yu Torshin
FSAEI HPE "Moscow Institute of Physics and Technology"Dolgoprudny
O. A Gromova
SBEI HPE "Ivanovo State Medical Academy" of RMPH
Email: unesco.gromova@gmail.com
MD, Prof. at the Department of Pharmacology and Clinical Pharmacology Ivanovo
References
- Акатова Е.В. Суханова Е.Д., Мельник О.О., Мартынов А.И. Динамика функционального состояния кардиоваскулярной системы у пациентов с идиопатическим пролапсом митрального клапана на фоне приема магнерота и алпразолама. Клин. мед. 2008;3(86):55-8.
- Громова О.А. Торшин И.Ю., Гришина Т.Р. Мировой опыт применения цитрата магния в медицине. Трудный пациент. 2010;8:35-41.
- Домницкая Т.М. Дьяченко А.В., Куприянова О.О., Домницкий М.В. Клиническое использование оротата магния у подростков с дисплазией соединительной ткани сердца. Кардиология. 2005;3(45):76-81.
- Мартынов А.И. Степура О.Б., Шехтер А.Б. и др. Лечение пациентов с идиопатическим пролапсом митрального клапана. Тер. архив. 2000;9(72):67-70.
- Степура О.Б. Томаева Е.Е., Зверева Т.В. Оротовая кислота как метаболический агент. Вестник Рос. акад. мед. наук. 2002;2:39-41.
- Classen H.G., Rom J. Magnesium orotate -experimental and clinical evidence. Intern. Med. 2004;42(3):491-501.
- Ezhov A.V., Pimenov L.T. Effect of adjuvant magnesium therapy on the quality of life and emotional status of elderly patients with stable angina. Adv. Gerontol. 2002;10:95-8.
- Geiss K.R. Stergiou N., Neuenfeld H.U., Jester H.G. Effects of magnesium orotate on exercise tolerance in patients with coronary heart disease. Cardiovasc. Drugs Ther. 1998;12(2):153-56.
- Jellinek H., Takacs E. Course of the progression of experimentally induced arteriosclerotic vessel wall changes after treatment with magnesium orotate. Arzneimittelforschun. 2000;50(12):1071-77.
- Joosten M.M., Gansevoort R.T., Mukamal K.J., Kootstra-Ros J.E., Feskens E.J., Geleijnse J.M., Navis G., Bakker S.J.; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2013;61(6):1161-67.
- Konishi M., Tashiro M., Inoue H. Magnesium and cardiac function. Clin. Calcium. 2012;22(8):1173-79.
- Motyl T., Krzeminski J., Podgurniak M., Witeszczak C., Zochowski P. Variability of orotic acid concentration in cow's milk. Endocr. Regul. 1991;25(1-2):79-82.
- Qu X., Jin F., Hao Y., Li H., Tang T., Wang H., Yan W., Dai K. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One. 2013;8(3):e57720.
- Rubenowitz E., Molin I., Axelsson G., Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology. 2000;11(4): 416-21.
- Salerno C., Crifo C. Diagnostic value of urinary orotic acid levels: applicable separation methods. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2002;781(1-2):57-71.
- Stepura O.B., Martynow A.I. Magnesium orotate in severe congestive heart failure (MACH). Int. J. Cardiol. 2008;132:25-31.
- Torshin I.Y., Gromova O.A. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science. 2011.
Supplementary files
